So far:
Credit Suisse upgrade to outperform: Target Price changes $26 -> $28.30
Maquarie retains neutral: Target Price changes $23.10 -> $23.15
Morgan Stanley retains equal-weight: Target Price $23.50
UBS retains buy: Target Price $28.50
I remember UBS predicted the EBIT upgrade a couple of weeks/months ago. They think BSL will have $5 net cash per share (!) by FY23 and note that we have not experienced the same upswing as US listed peers.
So far:Credit Suisse upgrade to outperform: Target Price changes...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.43 |
Change
0.110(0.54%) |
Mkt cap ! $8.990B | |||
| Open | High | Low | Value | Volume |
| $20.32 | $20.58 | $20.15 | $35.06M | 1.717M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 308 | $20.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.43 | 3123 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BSL (ASX) Chart |